Substantial clinical benefit values demonstrate a high degree of variability when stratified by time and geographic region

Wellington, Ian J.; Davey, Annabelle; Cote, Mark P.; Hawthorne, Benjamin C.; Dorsey, Caitlin G.; Garvin, Patrick; Messina, James C.; Hewitt, Cory R.; Mazzocca, Augustus D.

doi:10.1016/j.jseint.2022.10.003

Cited by 7 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In order for the current findings to be generalizable and applied by the researchers, a larger cohort is required. Additionally, the generalizability of the MCID, the PASS and the SCB has recently been addressed and questioned, since, among others, Wellington et al showed that there is no homogeneity between the SCBs of four different commonly exploited shoulder outcomes when separating patients by time or geographic region regarding shoulder arthroplasty [39].…”

Section: Discussionmentioning

confidence: 99%

Minimal Clinically Important Difference (MCID), Substantial Clinical Benefit (SCB), and Patient Acceptable Symptom State (PASS) of the Shoulder Disability Questionnaire (SDQ) in Patients Undergoing Rotator Cuff Repair

Longo

Papalia

Salvatore

et al. 2023

IJERPH

View full text Add to dashboard Cite

The Shoulder Disability Questionnaire (SDQ) is a Patient-Reported Outcome Measure (PROM) applied to evaluate shoulder surgery outcomes. The purpose of this study is to identify the accurate Minimal Clinically Important Difference (MCID), Substantial Clinical Benefit (SCB) and Patient Acceptable Symptom State (PASS) values for the SDQ score. A total of 35 patients (21 women and 16 men, mean age 76.6 ± 3.2 years) were followed up at 6 months postoperatively. To assess the patient’s health satisfaction and symptoms, anchor questions were used. The MCID and SCB values of the SDQ score for patients who underwent arthroscopic rotator cuff repair from inception to final follow-up were 40.8 and 55.6, respectively. A change of 40.8 in the SDQ score at 6 months after surgery shows that patients achieved a minimum clinically important improvement in their state of health, and a 55.6 change in the SDQ score reflects a substantial clinically important improvement. The PASS cut-off of the SDQ score at 6 months postoperatively ranged from 22.5 to 25.8. If an SDQ score of 22.5 or more is attained after surgery, the health condition can be recognized as acceptable by the majority of patients. These cut-offs will help with understanding specific patient results and allow clinicians to personally assess patient improvement after rotator cuff repair.

show abstract

Section: Discussionmentioning

confidence: 99%

Minimal Clinically Important Difference (MCID), Substantial Clinical Benefit (SCB), and Patient Acceptable Symptom State (PASS) of the Shoulder Disability Questionnaire (SDQ) in Patients Undergoing Rotator Cuff Repair

Longo

Papalia

Salvatore

et al. 2023

IJERPH

View full text Add to dashboard Cite

show abstract

“…The SCB is the change in PROM scores that reflect a patient feeling he or she substantially improved from a given intervention. 30 These different ways to assess patient "success" from various treatments and interventions highlight the power of PROMs and allow for a nuanced approach to evaluating improvement in patient health. 31 Work defining these clinically relevant PROM score changes (MCID and/or SCB) has been done across many orthopaedic subspecialties, including foot and ankle, 32,33 hand and upper extremity (including total shoulder arthroplasty), [34][35][36] total knee arthroplasty (TKA), [37][38][39][40][41] and spine.…”

Section: Using Patient-reported Outcome Measures Clinically-from the ...mentioning

confidence: 99%

“…The SCB is the change in PROM scores that reflect a patient feeling he or she substantially improved from a given intervention. 30 These different ways to assess patient “success” from various treatments and interventions highlight the power of PROMs and allow for a nuanced approach to evaluating improvement in patient health. 31…”

Section: Using Patient-reported Outcome Measures Clinically—from the ...mentioning

confidence: 99%

Operationalizing PROMs at the Musculoskeletal Practice and Policy Levels

Bernstein

Baumhauer

2023

J Am Acad Orthop Surg

View full text Add to dashboard Cite

There continues to be growing interest in patient-reported outcome measures (PROMs), especially as value-based healthcare initiatives gain more traction. Although it is well-established that PROMs can be useful in clinical research, how to operationalize PROMs in clinical care and policy initiatives remains a "work in progress." Following the design of a comprehensive PROM administration and routine collection system, orthopaedic surgeons and their patients can reap the benefits of PROMs in practice through improved shared clinical decisionmaking discussions at the individual patient level and closer symptom monitoring on a large scale, with improved resource allocation at the population health level. Although certain government and payer incentives exist to collect PROMs at present, it is reasonable to assume that future policy initiatives will begin to use the actual PROM scores to assess clinical outcomes. Orthopaedic surgeons with interest in this area should prioritize their involvement in policy discussion to ensure PROMs are being used appropriately in novel payment models and policy endeavors so that they are both evaluated and compensated fairly. Specifically, orthopaedic surgeons can help ensure appropriate risk adjustment of patients when this is being done. Undoubtedly, PROMs will only become a larger part of musculoskeletal care moving forward. Healthcare systems globally-including the United States-are unsustainable, with expenditures far outpacing gross domestic product and wages in many countries. 1 At the same time, quality is inconsistent and the outcomes that matter most to patients (eg, function, pain, mental health, and quality of life) are collected infrequently, measured by using unvalidated instruments, and are rarely used even when available. In the United States, there is a general consensus that this healthcare delivery system is broken; this has led to movement toward a system that focuses on optimizing value for patients. 2 The overarching goal of value-based health care (VBHC) is

show abstract

What Are the Diagnosis-Specific Thresholds of Minimal Clinically Important Difference and Patient Acceptable Symptom State in Hip Disability and Osteoarthritis Outcome Score After Primary Total Hip Arthroplasty?

Emara,

Pasqualini,

Jin

et al. 2024

The Journal of Arthroplasty

View full text Add to dashboard Cite

Substantial clinical benefit values demonstrate a high degree of variability when stratified by time and geographic region

Cited by 7 publications

References 18 publications

Minimal Clinically Important Difference (MCID), Substantial Clinical Benefit (SCB), and Patient Acceptable Symptom State (PASS) of the Shoulder Disability Questionnaire (SDQ) in Patients Undergoing Rotator Cuff Repair

Minimal Clinically Important Difference (MCID), Substantial Clinical Benefit (SCB), and Patient Acceptable Symptom State (PASS) of the Shoulder Disability Questionnaire (SDQ) in Patients Undergoing Rotator Cuff Repair

Operationalizing PROMs at the Musculoskeletal Practice and Policy Levels

What Are the Diagnosis-Specific Thresholds of Minimal Clinically Important Difference and Patient Acceptable Symptom State in Hip Disability and Osteoarthritis Outcome Score After Primary Total Hip Arthroplasty?

Contact Info

Product

Resources

About